Literature DB >> 20497959

Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.

Yasuhiro Maeda1, Noriyasu Seki, Noriko Sato, Kunio Sugahara, Kenji Chiba.   

Abstract

Sphingosine 1-phosphate (S1P) and its receptor, S1P receptor type 1 (S1P(1)), are essential for lymphocyte egress from secondary lymphoid organs (SLO). Fingolimod (FTY720), the S1P receptor modulator, inhibits lymphocyte egress from SLO and decreases circulating lymphocytes; however, it also induces a significant decrease in the number of peripheral blood lymphocytes in alymphoplasia (aly/aly) mice lacking SLO. In this study, we demonstrated that the administration of FTY720 induced sequestration of mature lymphocytes, particularly T cells, into the bone marrow (BM) in aly/aly mice, implying that the reduction of circulating lymphocytes in these mice by FTY720 was due to inhibition of lymphocyte egress from the BM. Since sequestration of mature T cells into the BM was also induced in normal mice by selective S1P(1) agonist or S1P lyase inhibitor, it is suggested that S1P(1) expression and the S1P gradient play an important role in egress of mature T cells from the BM. Prophylactic administration of FTY720 to ovalbumin (OVA)-immunized mice significantly inhibited footpad swelling induced by OVA challenging with a marked reduction of OVA-specific T(h) cells in the BM, indicating that immunomodulation by FTY720 is likely due to reduced circulation of antigen-specific T(h) cells. On the other hand, OVA-specific T(h) cells, like naive T cells, were also sequestered into the BM and SLO of OVA-immunized mice by a short exposure of FTY720 after OVA challenging. These results suggest that the S1P-S1P(1) axis plays a regulatory role in egress of mature T cells including antigen-specific T(h) cells from the BM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20497959     DOI: 10.1093/intimm/dxq036

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  22 in total

1.  Preexisting malignancy abrogates the beneficial effects of CXCR4 blockade during sepsis.

Authors:  Wenxiao Zhang; Deena B Chihade; Jianfeng Xie; Ching-Wen Chen; Kimberly M Ramonell; Zhe Liang; Craig M Coopersmith; Mandy L Ford
Journal:  J Leukoc Biol       Date:  2020-01-27       Impact factor: 4.962

2.  Type II membrane protein CD69 regulates the formation of resting T-helper memory.

Authors:  Kenta Shinoda; Koji Tokoyoda; Asami Hanazawa; Koji Hayashizaki; Sandra Zehentmeier; Hiroyuki Hosokawa; Chiaki Iwamura; Haruhiko Koseki; Damon J Tumes; Andreas Radbruch; Toshinori Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 3.  Targeting the molecular and cellular interactions of the bone marrow niche in immunologic disease.

Authors:  Jaime M Brozowski; Matthew J Billard; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2014-02       Impact factor: 4.806

4.  The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction.

Authors:  Nicholas Collins; Seong-Ji Han; Michel Enamorado; Verena M Link; Bonnie Huang; E Ashley Moseman; Rigel J Kishton; John P Shannon; Dhaval Dixit; Susan R Schwab; Heather D Hickman; Nicholas P Restifo; Dorian B McGavern; Pamela L Schwartzberg; Yasmine Belkaid
Journal:  Cell       Date:  2019-08-22       Impact factor: 41.582

Review 5.  The outs and the ins of sphingosine-1-phosphate in immunity.

Authors:  Sarah Spiegel; Sheldon Milstien
Journal:  Nat Rev Immunol       Date:  2011-05-06       Impact factor: 53.106

6.  The effect of sphingosine-1-phosphate on bone metabolism in humans depends on its plasma/bone marrow gradient.

Authors:  B-J Kim; K-O Shin; H Kim; S H Ahn; S H Lee; C-H Seo; S-E Byun; J S Chang; J-M Koh; Y-M Lee
Journal:  J Endocrinol Invest       Date:  2015-07-29       Impact factor: 4.256

7.  Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D.

Authors:  Junichi Kikuta; Shunsuke Kawamura; Fumie Okiji; Mai Shirazaki; Sadaoki Sakai; Hitoshi Saito; Masaru Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

8.  Where Have All the T Cells Gone?

Authors:  Gerlanda Vella; Gabriele Bergers
Journal:  Immunity       Date:  2018-10-16       Impact factor: 31.745

Review 9.  Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts.

Authors:  Tamara Pérez-Jeldres; Christopher J Tyler; Joshua D Boyer; Thangaraj Karuppuchamy; Giorgos Bamias; Parambir S Dulai; Brigid S Boland; William J Sandborn; Derek R Patel; Jesús Rivera-Nieves
Journal:  Inflamm Bowel Dis       Date:  2019-01-10       Impact factor: 5.325

Review 10.  Lymphatic Vessels Enhancing Adaptive Immunity Deteriorates Renal Inflammation and Renal Fibrosis.

Authors:  Jianliang Wu; Guangchang Pei; Rui Zeng; Gang Xu
Journal:  Kidney Dis (Basel)       Date:  2020-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.